Clinical Trial Update: Vaginal Progesterone for Prevention of Preterm Labor in Asymptomatic Twin Pregnancies With Sonographic Short Cervix [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial evaluating vaginal progesterone to prevent preterm labor in asymptomatic twin pregnancies with a short cervix has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Preterm Labor

Drugs mentioned

• Vaginal progesterone (progesterone)

Snippet

Sponsor: Mohamed Sayed Abdelhafez | Conditions: Premature Labour | Phase 4 | Status: COMPLETED